Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:13 PM
Ignite Modification Date:
2025-12-24 @ 10:13 PM
NCT ID:
NCT00536835
Eligibility Criteria:
Inclusion Criteria:
* Confirmed diagnosis of advanced solid tumor or Non-Hodgkins Lymphoma (excluding HIV-associated lymphoma) that has relapsed or is refractory to standard therapies
* At least 18 years of age
* Female who are of non-childbearing potential or who have a negative pregnancy test who uses approved contraception
* Male with a female partner of childbearing potential must have had a vasectomy or both are using approved contraception
* Lab values that are within range as described in the protocol
* Paraffin-embedded archival tumor tissue available for testing
* Signed written informed consent
Exclusion Criteria:
* Undergone major surgery or received anti-cancer therapy
* History of hemolytic anemia
* Clinical lab tests that are out of range as described in the protocol
* Females who are pregnant or lactating
* Significant heart problems
* Serious or unstable pre-existing medical or psychiatric condition
* Are not able to comply with the study protocol
* Use of prohibited medications
* Have low blood pressure
* Evidence of symptomatic or untreated central nervous system involvement and require corticosteroids or anti-epileptic meds
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00536835
Study Brief:
Protocol Section:
NCT00536835